pfmh-hCry1 Citations (5)

Originally described in: A. Sancar lab plasmid
Unpublished

---

Articles Citing pfmh-hCry1

Articles
Deregulated expression of cryptochrome genes in human colorectal cancer. Mazzoccoli G, Colangelo T, Panza A, Rubino R, De Cata A, Tiberio C, Valvano MR, Pazienza V, Merla G, Augello B, Trombetta D, Storlazzi CT, Macchia G, Gentile A, Tavano F, Vinciguerra M, Bisceglia G, Rosato V, Colantuoni V, Sabatino L, Piepoli A. Mol Cancer. 2016 Jan 15;15:6. doi: 10.1186/s12943-016-0492-8. PubMed
The cryptochrome inhibitor KS15 enhances E-box-mediated transcription by disrupting the feedback action of a circadian transcription-repressor complex. Jang J, Chung S, Choi Y, Lim HY, Son Y, Chun SK, Son GH, Kim K, Suh YG, Jung JW. Life Sci. 2018 May 1;200:49-55. doi: 10.1016/j.lfs.2018.03.022. Epub 2018 Mar 10. PubMed
Cryptochromes-Mediated Inhibition of the CRL4(Cop1)-Complex Assembly Defines an Evolutionary Conserved Signaling Mechanism. Rizzini L, Levine DC, Perelis M, Bass J, Peek CB, Pagano M. Curr Biol. 2019 Jun 17;29(12):1954-1962.e4. doi: 10.1016/j.cub.2019.04.073. Epub 2019 May 30. PubMed
Circadian Oscillations Persist in Cervical and Esophageal Cancer Cells Displaying Decreased Expression of Tumor-Suppressing Circadian Clock Genes. van der Watt PJ, Roden LC, Davis KT, Parker MI, Leaner VD. Mol Cancer Res. 2020 Sep;18(9):1340-1353. doi: 10.1158/1541-7786.MCR-19-1074. Epub 2020 Jun 5. PubMed
Development of Non-Ethoxypropanoic Acid Type Cryptochrome Inhibitors with Circadian Molecular Clock-Enhancing Activity by Bioisosteric Replacement. Jeong YU, Jin HE, Lim HY, Choi G, Joo H, Kang B, Lee GH, Liu KH, Maeng HJ, Chung S, Son GH, Jung JW. Pharmaceuticals (Basel). 2021 May 24;14(6). pii: ph14060496. doi: 10.3390/ph14060496. PubMed

If you have published an article using this material, please email us at to have your article added to this page.